Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels
NCT05349292 is an observational study sponsored by University of Maryland, Baltimore. As of 18 Nov 2026, it is recruiting participants. It studies Acute Kidney Injury. The registry lists an enrollment of 100 participants at 1 site in 1 country. The registry lists a start date of 31 Jan 2024 and a primary completion date of 30 Jun 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05349292 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | University of Maryland, Baltimore |
| Enrollment | 100 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Acute Kidney Injury |
| Start | 31 Jan 2024 |
| Primary completion | 30 Jun 2027 |
| Study completion | 31 Dec 2027 |
| Last update posted | 1 May 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Patrick Odonkor, MD
University of Maryland, Baltimore
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Maryland Medical Center
Baltimore
Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05349292
Each answer restates registry values shown on this page.
What is NCT05349292?
NCT05349292 is an observational study sponsored by University of Maryland, Baltimore. It studies Acute Kidney Injury.
Is NCT05349292 recruiting?
As of 18 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT05349292?
The registry names Patrick Odonkor, MD (principal investigator, University of Maryland, Baltimore) as the overall official.
Where does NCT05349292 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT05349292 expected to complete?
The registry lists a primary completion date of 30 Jun 2027 and a study completion date of 31 Dec 2027. The sponsor last updated the record on 1 May 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.